dantrolene has been researched along with Benign Neoplasms in 1 studies
Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.
Excerpt | Relevance | Reference |
---|---|---|
"Eleven patients with various cancer types from ten case reports published from 1988 to 2013 met the eligibility criteria." | 2.66 | Neuroleptic malignant syndrome in patients with cancer: a systematic review. ( Ishida, M; Kawakami, K; Kawanishi, C; Onishi, H; Sato, I; Yamada, S, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Sato, I | 1 |
Onishi, H | 1 |
Kawanishi, C | 1 |
Yamada, S | 1 |
Ishida, M | 1 |
Kawakami, K | 1 |
1 review available for dantrolene and Benign Neoplasms
Article | Year |
---|---|
Neuroleptic malignant syndrome in patients with cancer: a systematic review.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Dantrolene; Dopamine D2 Receptor Antagonists; | 2020 |